retatrutide clinical studies Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial Triple hormone receptor agonist retatrutide
Description
Wegovy is a weight loss medication approved by the FDA
Expect an adjustment period, possible dosage changes, and mild side effects, but overall, it's manageable.
Discover how this GLP-1 weight management medication affects your stomach, learn to recognise gastritis symptoms, and find out when to seek medical advice for gastrointestinal side effects.
Do not use Retatrutide in combination with other medicines that contain GLP-1 receptor agonists
Ozempic can be prescribed off-label to help with weight loss but some users say it can cause unusual dreams
It caused tumors in animal studies
